Tinengotinib
Product Specifications
CAS Number
2230490-29-4
Synonyms
TT-00420
Target
Aurora Kinase
Applications
Cell Cycle
Molecular Formula
C20H19ClN6O
Additionnal Information
Tinengotinib (TT-00420) is a novel multiple kinase inhibitor that strongly inhibits Aurora A/B with IC50 values of 1.2/3.3 nM respectively. It also exhibits potent inhibitory activity on FGFR1/2/3, VEGFR1, JAK1/2, and CSF1R and can be used to treat several prominent signaling pathways in triple-negative breast cancer (TNBC) .
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6290567-01 0.1 mL
CYSLTR1, ID (CYSLTR1, CYSLT1, Cysteinyl leukotriene receptor 1, Cysteinyl leukotriene D4 receptor, G-protein coupled receptor HG55, HMTMF81) (MaxLight 405)
Sign In for Pricing
View Details MBS6290567-02 5x 0.1 mL
CYSLTR1, ID (CYSLTR1, CYSLT1, Cysteinyl leukotriene receptor 1, Cysteinyl leukotriene D4 receptor, G-protein coupled receptor HG55, HMTMF81) (MaxLight 405)
Sign In for Pricing
View Details MBS1477299-01 0.02 mg (E-Coli)
Recombinant Salmonella choleraesuis Pyridoxamine kinase (pdxY)
Sign In for Pricing
View Details MBS1477299-02 0.02 mg (Yeast)
Recombinant Salmonella choleraesuis Pyridoxamine kinase (pdxY)
Sign In for Pricing
View Details MBS1477299-03 0.1 mg (E-Coli)
Recombinant Salmonella choleraesuis Pyridoxamine kinase (pdxY)
Sign In for Pricing
View Details